Related Experiment Video
Updated: Apr 21, 2026

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy
Published on: October 31, 2025
Regional ischemic immune myopathy: a paraneoplastic dermatomyopathy
Chunyu Cai1, Ali Alshehri, Rati Choksi
1From the Departments of Pathology and Immunology (CC, AP), and Neurology (AA, RC, AP), Washington University School of Medicine, St. Louis, Missouri.
Abstract:
Necrosis and regeneration of scattered muscle fibers are common features of many active acquired and immune myopathies. We studied a series of patients with acquired myopathies with an unusual pattern of regional, rather than scattered, muscle fiber necrosis and regeneration. Retrospective review of records of 7 patients with acquired myopathies having regional muscle fiber necrosis on muscle biopsy. Clinical features of patients included proximal symmetric weakness in arms and legs with a subacute onset (100%) beginning at ages between 41 and 92 years, with dysphagia (83%), myalgias (100%), skin rash (67%), and associated malignancy (71%). Serum creatine kinase was often very high (>1,600 U/L) (83%). Survival was less than 1 year in 43%. Myopathology included a regional distribution with muscle fiber necrosis and capillary loss in the border zones between intermediate-sized perimysial vessels, vascular pathology with damaged walls of intermediate-sized perimysial veins, and connective tissue with expression of the ischemia marker carbonic anhydrase IX but no mononuclear cell inflammatory foci. These data indicate that regional ischemic immune myopathies are likely caused by ischemia in border zones between damaged intermediate-sized perimysial blood vessels. Regional ischemic immune myopathies are a distinctive pathologic group of acquired, probably immune, noninflammatory dermatomyopathies with weakness and often a skin rash and systemic neoplasm.
More Related Videos
09:38Minimally Invasive Isolated Limb Perfusion (MI-ILP) for Locally Advanced Melanomas and Sarcomas of the Extremity
Published on: January 31, 2025
08:57Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
Related Concept Videos
Myasthenia Gravis ll: Pathophysiology
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis I: Introduction
Multiple Sclerosis l: Introduction